Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: Leuk Lymphoma. 2010 Jan 18;51(3):475–480. doi: 10.3109/10428190903503412

Table II.

Salvage therapy categories (n = 172).

Therapy n (%)
VAD–Hyper CVAD 113 (66)
Cytarabine combinations 20 (12)
Allogeneic stem cell transplant 14 (8)
Methotrexate-asparaginase 5 (3)
Other combinations 9 (5)
Single agent 11 (6)

VAD, vincristine, doxorubicin, and dexamethasone; Hyper-CVAD, fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone.